241 related articles for article (PubMed ID: 11362964)
1. Closing the circle on HIV--or not.
Mascolini M
J Int Assoc Physicians AIDS Care; 1995 Oct; 1(9):10-4, 17-29 contd. PubMed ID: 11362964
[TBL] [Abstract][Full Text] [Related]
2. ACTG 175 and Delta.
Torres G
GMHC Treat Issues; 1995 Oct; 9(10):2-3. PubMed ID: 11362915
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy increases survival.
Treat Rev; 1995 Nov; (no 20):2-3. PubMed ID: 11363019
[TBL] [Abstract][Full Text] [Related]
4. Studies of zidovudine in combination with didanosine and zalcitabine.
Jablonowski H
J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
[TBL] [Abstract][Full Text] [Related]
5. Top AIDS researchers' strategy for antiretroviral treatment.
AIDS Alert; 1996 Sep; 11(9):97-100. PubMed ID: 11363728
[TBL] [Abstract][Full Text] [Related]
6. Back to the nukes.
Smart T
GMHC Treat Issues; 1996 Feb; 10(2):6-7. PubMed ID: 11363383
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
8. A Lisbon traviata. Are clinicians ready to sing addio to monotherapy and libiamo to combinations?
Mascolini M
J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):10-20, 22. PubMed ID: 11362792
[TBL] [Abstract][Full Text] [Related]
9. Review of viral load and combination therapy data from 35th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy.
Bray JM
STEP Perspect; 1995; 7(3):10-1. PubMed ID: 11362980
[TBL] [Abstract][Full Text] [Related]
10. Update on HIV protease inhibitors.
Vella S
AIDS Clin Care; 1995 Oct; 7(10):79-82, 88. PubMed ID: 11362832
[TBL] [Abstract][Full Text] [Related]
11. To treat or not to treat--approaches to antiretroviral therapy. Interview by Anthony J. Japour.
Coombs R; Cotton D; Hammer S; Saag M; van der Horst C
AIDS Clin Care; 1996 Jan; 8(1):1-4. PubMed ID: 11363056
[TBL] [Abstract][Full Text] [Related]
12. AZT studies reinforce benefits of combination.
AIDS Alert; 1995 Jan; 10(1):11-2. PubMed ID: 11362167
[TBL] [Abstract][Full Text] [Related]
13. Protease inhibitors and prevention of cross resistance.
Levin J
AIDS Treat News; 1995 Oct; (no 232):1-3. PubMed ID: 11362875
[TBL] [Abstract][Full Text] [Related]
14. Studies confirm value of early and combination treatments.
Vazquez E
Posit Aware; 1995; VI(6):8. PubMed ID: 11363148
[TBL] [Abstract][Full Text] [Related]
15. Making sense of 175 and Delta.
Smart T
GMHC Treat Issues; 1995 Oct; 9(10):4. PubMed ID: 11362916
[TBL] [Abstract][Full Text] [Related]
16. Protease inhibitors.
Schouten JT
STEP Perspect; 1995; 7(3):12-3. PubMed ID: 11362981
[TBL] [Abstract][Full Text] [Related]
17. Benefits of combination therapy confirmed.
Cheng B
PI Perspect; 1995 Dec; (no 17):3-4. PubMed ID: 11363111
[TBL] [Abstract][Full Text] [Related]
18. Merck protease inhibitor: more news from Retroviruses Conference.
James JS
AIDS Treat News; 1996 Feb; (no 241):1-3. PubMed ID: 11363186
[TBL] [Abstract][Full Text] [Related]
19. New trials reach same conclusion: two drugs are better than AZT alone.
AIDS Alert; 1995 Nov; 10(11):133-6. PubMed ID: 11362921
[TBL] [Abstract][Full Text] [Related]
20. FDA triple header. Food and Drug Administration.
Smart T
GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]